In this post in the Center for Global Development’s (CGD) “Global Health Policy” blog, Amanda Glassman, director of global health policy and a research fellow at the center, reports on the contribution of economists to the global health field, writing, “Economists are not global health’s most popular human resource. … Yet a new view of the contribution of economists to global health is emerging.” She notes, “At the International AIDS Economics Network (IAEN) meeting earlier this month, [U.S. Global AIDS Coordinator] Ambassador Eric Goosby gave a terrific overview of the policy questions that need to be addressed by the field and the role that economists need to play in improving the efficiency and effectiveness of the HIV/AIDS response,” and provides a number of quotes from his address (8/1).
Programs, Funding & Financing
On the first stop of a 10-day tour of Africa, Secretary of State Hillary Clinton stopped at the Phillipe Maguilen Senghor Health Center in Dakar, Senegal, where Awa Marie Coll-Seck, the country’s minister of health, “explained to Secretary Clinton how these operational centers dramatically improve maternal and child health,” according to a post in USAID’s “IMPACTblog.” Coll-Seck “also noted that USAID-supported distribution of insecticide impregnated mosquito nets across the country had drastically reduced the incidence of malaria,” according to the blog, which adds that Clinton “was pleased to hear that the United States is playing a key role in helping meet one of its biggest challenges: decentralizing services so they are available at the village level throughout the country.” In an address several hours later, “Clinton invoked the Senghor center … saying she was highly impressed by the integrated nature of the facility” and that “[i]t was a successful model she hoped could be duplicated throughout Senegal and the entire West African region” (Taylor, 8/1).
PEPFAR on Wednesday “announced awards for a $60 million initiative, with potential for additional funding in year three, to support implementation science research and the evaluation of programs established under PEPFAR,” according to a U.S. State Department media note. “These evaluations, funded through collaboration with the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the U.S. Agency for International Development (USAID), will contribute to the evidence base for HIV programs and maximize the impact of its investments in programs around the world. Data gathered will help partner countries to strengthen their efforts to prevent new HIV infections and save lives,” the media note states, adding, “More than 35 evaluations in over 12 countries will be funded in 2012” (8/1).
The Financial Times on Wednesday published a special report (.pdf) on global health policy to coincide with the Global Health Policy Summit in London. The special report features 10 articles on a variety of topics, including an article examining the complexities of applying health policies, delivering treatment and measuring program performances on a global level; an article highlighting potential strategies for lowering health care costs globally; and an article discussing the need for innovative approaches to combating infectious diseases (8/1).
“PrePex, a bloodless circumcision device for adults, will be tested in at least nine African countries in the next year, according to the backers of the tests,” the New York Times reports. PEPFAR “will pay for PrePex circumcisions for about 2,500 men in Lesotho, Malawi, South Africa, Tanzania and Uganda, said Dr. Jason B. Reed, a technical adviser to the plan,” the newspaper writes. “The Bill & Melinda Gates Foundation will pay for similar studies in Kenya, Mozambique, South Africa, Zambia and Zimbabwe,” it adds. According to the New York Times, the device “was approved by the Food and Drug Administration in January, and World Health Organization approval is expected soon.” The newspaper notes, “No surgeon is needed for the procedure; a two-nurse team slides a grooved ring inside the foreskin and guides a rubber band to compress the foreskin in the groove,” and adds, “After a week, the dead foreskin falls off like the stump of a baby’s umbilical cord or can be painlessly clipped off, said Tzameret Fuerst, chief executive of PrePex” (McNeil, 8/13).
In this post in Huffington Post’s “Impact” blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines “the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria.” She highlights U.S. Secretary of State Hillary Clinton’s recent trip to Africa, writing that Clinton’s “encouraging words” at the Reach Out Mbuya health center in Uganda reinforced U.S. commitment to an AIDS-free generation. She notes both PEPFAR and the Global Fund have supported the center and adds that “through hundreds of similar local programs all over the world, the Global Fund provides treatment to 3.6 million people who are HIV-positive.”
In this post in BMJ’s “Yankee Doodling,” Douglas Kamerow, chief scientist at RTI International and an associate editor for the journal, reflects on the possibility of achieving an AIDS-free generation “if somehow we succeeded in getting all HIV positive people in the world identified and under long term treatment.” He writes that while there has been “astonishing progress against AIDS,” “two concerns immediately arise: the magnitude of the work remaining to find and continuously treat all those infected, and the confusion between that treatment (even if it is somehow universally successful) and actual eradication of the disease.” He concludes, “It is a rosy scenario, but even if it came true it still would not spell the end of the HIV story,” because “[w]e have no vaccine, and the virus keeps mutating” (8/14).
“The United Nations’ World Food Program [WFP] is appealing for $87 million to avert starvation in Zimbabwe’s rural areas where close to two million people need food aid,” VOA News reports, adding, “The U.N. agency says because of poor rainfall, this year’s hunger season in Zimbabwe has started earlier than in the past.” The news service highlights the “dire food situation” in the rural area of Buhera, part of Manicaland province, which “is one of the four regions the [WFP] says are worst affected by drought in Zimbabwe.” “We hear of people starting to sell their livestock at distress prices, reducing their number of meals in rural Zimbabwe, which is a clear indication that the food security situation is worsening,” Liliana Yovcheva of the WFP program office in Zimbabwe said, according to the news service (8/13).
“With one billion people chronically hungry and Earth’s population expected to increase by 50 percent before the end of the century, it’s time to get serious about family planning,” a Los Angeles Times editorial states. “At one point, the prevailing wisdom was that nations needed robust birthrates to protect their economic welfare, and that if only we could produce food more efficiently, feeding the Earth’s burgeoning population wouldn’t be a problem,” it continues, adding, “Now â€¦ we know better. Or we ought to.” The editorial continues, “No one has a good solution. That’s why family planning assistance is one of the most important forms of humanitarian aid that the United States and other developed nations can provide.” It concludes, “Without the necessary resources and an existing economy prepared to absorb large numbers of new workers, nations that promote high birthrates set themselves up for economic distress and political unrest” (8/10).
“When you’re dealing with a global public health crisis, having an international presence isn’t just advisable — it is imperative,” Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI), writes in this post in USAID’s “Impact” blog, adding, “That’s why [IAVI], in partnership with USAID, has worked diligently over the past several years to establish itself as a truly global non-profit partner.” She continues, “IAVI has created an enviable network of research centers in sub-Saharan Africa dedicated to assessing novel AIDS vaccine candidates in clinical trials and conducting supporting epidemiological studies on HIV,” and writes that these “partnerships have made meaningful contributions to the research capacity of many developing countries — a capability that is now helping local researchers tackle other diseases” (8/13).